The effect of GLP-1R agonists liraglutide and exendin-4 was examined in vitro on LOVO, CA-77, MCF-7, MDA-MB-231, KPL-1, MB-468, 4TI, BT483, ZR751, LNCap, PC3, ALVA-41, DU145, LNCap, PANC-1, MiaPaCa-2, PANC, CT26, SKOV3, OVCAR3, OVCAR4, A2780, and ES-2 cell lines that are expressed in several cancers including colorectal, pancreatic, thyroid, breast, prostate, ovarian, and colon (Table 1)
Those on anticoagulant medication L-Carnitine might interfere with blood-thinning drugs
4.4 Glucagon-like peptide-1/GLP-1 receptor agonists Endogenous and pharmacological activation of the GLP-1 receptor (GLP-1R) axis is thought to be reno-protective in DM (177)
Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up